CVE-2019-5024

Description

A restricted environment escape vulnerability exists in the “kiosk mode” function of Capsule Technologies SmartLinx Neuron 2 medical information collection devices running versions 9.0.3 or lower. A specific series of keyboard inputs can escape the restricted environment, resulting in full administrator access to the underlying operating system. An attacker can connect to the device via USB port with a keyboard or other HID device to trigger this vulnerability.

Category

7.6
CVSS
Severity: High
CVSS 3.1 •
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.05%
Third-Party Advisory talosintelligence.com
Affected: Capsule Technologies Capsule Technologies SmartLinx Neuron 2
Published at:
Updated at:

References

Link Tags
https://talosintelligence.com/vulnerability_reports/TALOS-2019-0785 third party advisory

Frequently Asked Questions

What is the severity of CVE-2019-5024?
CVE-2019-5024 has been scored as a high severity vulnerability.
How to fix CVE-2019-5024?
To fix CVE-2019-5024, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2019-5024 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2019-5024 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2019-5024?
CVE-2019-5024 affects Capsule Technologies Capsule Technologies SmartLinx Neuron 2.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.